Coversin

DRUG2 trials

Sponsors

AKARI Therapeutics

Conditions

Paroxysmal Nocturnal Haemoglobinuria (PNH)Paroxysmal Nocturnal Hemoglobinuria (PNH)

Phase 2

Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH)

CompletedNCT02591862

AKARI TherapeuticsParoxysmal Nocturnal Haemoglobinuria (PNH)

Start: 2016-02-29End: 2018-03-20Updated: 2023-07-12

Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms

CompletedNCT03427060

AKARI TherapeuticsParoxysmal Nocturnal Hemoglobinuria (PNH)

Start: 2018-05-14End: 2021-02-03Updated: 2025-05-04